Top and Current
Source: (remove) : Etzer Darout
RSSJSONXMLCSV
Top and Current
Source: (remove) : Etzer Darout
RSSJSONXMLCSV
Mon, September 16, 2024
Tue, August 13, 2024
Fri, August 9, 2024
Tue, August 6, 2024
Fri, June 14, 2024
Thu, June 13, 2024
Wed, May 15, 2024
Tue, May 7, 2024
Fri, April 26, 2024
Mon, April 1, 2024
Thu, March 21, 2024
Fri, March 15, 2024
Mon, March 4, 2024
Wed, February 28, 2024
Fri, February 23, 2024
Mon, February 12, 2024
Fri, November 10, 2023
Fri, November 3, 2023
Tue, August 1, 2023
Mon, May 8, 2023
Mon, April 3, 2023
Mon, January 30, 2023
Thu, January 5, 2023
Tue, November 1, 2022
Fri, June 24, 2022
Mon, April 11, 2022
Fri, February 11, 2022
Thu, February 3, 2022
Mon, July 12, 2021
Fri, February 26, 2021
Mon, February 22, 2021
Wed, March 28, 2018

Etzer Darout Reiterated (ACRV) at Buy with Increased Target to $28 on, Sep 16th, 2024


Published on 2024-10-28 14:16:21 - WOPRAI, Etzer Darout
  Print publication without navigation


Etzer Darout of BMO Capital, Reiterated "Acrivon Therapeutics, Inc." (ACRV) at Buy with Increased Target from $25 to $28 on, Sep 16th, 2024.

Etzer, nor any peers, have made any analyst calls on ACRV in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30